Halford, W. P., & Schaffer, P. A. (2000). Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo. American Society for Microbiology.
Chicago-стиль цитированияHalford, William P., and Priscilla A. Schaffer. Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo. American Society for Microbiology, 2000.
MLA-цитированиеHalford, William P., and Priscilla A. Schaffer. Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo. American Society for Microbiology, 2000.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.